newsfilter
← Latest News
GlobeNewswire·

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

BOCA RATON, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (NASDAQ:ENTO) ("Entero" or the "Company"), a late clinical-stage biopharmaceutical company focused on